Therapeutic drug monitoring of patients with psoriasis during tumour necrosis factor (TNF)-α antagonist treatment using a novel interleukin-8 reporter cell line
Yutaka Kimura(Tohoku University), Setsuya Aiba(Tohoku University), Toshiya Takahashi(Tohoku University), Rika Nishikawa(Kobe University), Chikako Nishigori(Japanese Red Cross Kobe Hospital), Kenichiro Tsuchiyama(Tohoku University), Ryoko Shimada‐Omori(Tohoku University), Yoshiyuki Kusakari(Tohoku University), Kenshi Yamasaki(Tohoku University)
Cited by 5
Related Papers
Synergistic Effect of Nod1 and Nod2 Agonists with Toll-Like Receptor Agonists on Human Dendritic Cells To Generate Interleukin-12 and T Helper Type 1 Cells
|Infection and Immunity|2005|361
Dermatofibrosarcoma protuberans is a unique fibrohistiocytic tumour expressing CD34
|British Journal of Dermatology|1992|235
Hgs (Hrs), a FYVE Domain Protein, Is Involved in Smad Signaling through Cooperation with SARA
|Molecular and Cellular Biology|2000|177
Activation of Epidermal Toll-Like Receptor 2 Enhances Tight Junction Function: Implications for Atopic Dermatitis and Skin Barrier Repair
|Journal of Investigative Dermatology|2012|171
Notch signaling: Its role in epidermal homeostasis and in the pathogenesis of skin diseases
|Journal of Dermatological Science|2007|163